Alpine Immune Sciences Announces Poster Presentation at 2017 ACR/ARHP Annual Meeting SEATTLE, WA–(BUSINESS WIRE)—September 20, 2017– Alpine Immune Sciences, Inc….
Alpine Immune Sciences to Present at Ladenburg Thalmann 2017 Healthcare Conference SEATTLE, WA –September 13, 2017– Alpine Immune Sciences, Inc….
Boulder, CO, July 20, 2017 – Nivalis Therapeutics, Inc. (Nivalis) (Nasdaq:NVLS) announced today that, based upon the final vote count...Read More
Alpine Immune Sciences Announces Presentation of Preclinical Data Showing Potency of Its First-Generation Dual ICOS and CD28 Antagonist vIgDs in...Read More
Nivalis Therapeutics, Inc. and Alpine Immune Sciences, Inc. Agree to Combine - Plan to Accelerate Development of Novel Immunotherapies Focused...Read More